← Back to Search

Intervention Group Arm for Cancer

N/A
Waitlist Available
Led By Manali I Patel, MD MPH MS
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days prior to death for patients who died at 12-months follow-up
Awards & highlights

Study Summary

This trial will test whether a lay health worker-led intervention can improve symptom burden for patients with cancer, and whether this leads to improved survival rates, lower healthcare costs, and less use of acute care.

Eligible Conditions
  • Cancer
  • End of Life

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days prior to death for patients who died at 12-months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days prior to death for patients who died at 12-months follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Edmonton Symptom Assessment Scale (ESAS) Symptom Screen
Personal Health Questionnaire-9 (PHQ-9) Depression Screen
Secondary outcome measures
% of patients with Emergency Department Visit in the last 30 days of life (Chart Review)
% of patients with Emergency Department Visit within 12-months after patient enrollment (Chart Review)
% of patients with Hospitalization Visits in the last 30 days of life (Chart Review)
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group ArmExperimental Treatment2 Interventions
Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: proactive symptom assessments for patients for up to 12-months.
Group II: Control Group ArmActive Control1 Intervention
The control group arm will receive usual care as provided by their local oncologists.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Program participants
2015
N/A
~840

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,382 Previous Clinical Trials
17,332,858 Total Patients Enrolled
Manali I Patel, MD MPH MSPrincipal InvestigatorStanford University
3 Previous Clinical Trials
600 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Enhancing Community Capacity to Improve Cancer Care Delivery
Manali Indravadan Patel 2015. "Enhancing Community Capacity to Improve Cancer Care Delivery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04107116.
~88 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top